HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$34.63
Day range
$33.81 - $34.98
Year range
$10.91 - $34.98
Market cap
2.69B USD
Avg Volume
704.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.64M | 9.33% |
Net income | -11.18M | 83.80% |
Net profit margin | — | — |
Earnings per share | -0.15 | 88.97% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 486.20M | 17.37% |
Total assets | 504.60M | 19.83% |
Total liabilities | 49.50M | -47.17% |
Total equity | 455.10M | — |
Shares outstanding | 77.59M | — |
Price to book | 7.00 | — |
Return on assets | -27.26% | — |
Return on capital | -31.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.18M | 83.80% |
Cash from operations | -37.12M | -26.16% |
Cash from investing | 25.00M | -41.51% |
Cash from financing | -4.64M | -136.33% |
Net change in cash | -16.76M | -164.19% |
Free cash flow | -68.93M | -510.63% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
95
